CharacterisatiON of carDiac funCTion in Intensive Care Unit Survivors of Sepsis.

NCT05633290 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2023-03-08

No results posted yet for this study

Summary

Cardiac dysfunction is common following hospital admission with sepsis and one of the most frequent causes for readmissions to hospital, however underlying mechanisms by which this might occur are unclear. The CONDUCT-ICU investigators will conduct a pilot, cohort study, characterizing cardiac function in ICU survivors of sepsis using a combination of CMR imaging, biomarkers and patient reported outcome measures to investigate mechanisms of cardiac dysfunction following sepsis. Comparisons will be made to that of the general population.

Conditions

Interventions

DIAGNOSTIC_TEST

CMR

CMR Imaging 6-10 weeks post hospital discharge.

DIAGNOSTIC_TEST

hs-troponin

Biomarker of myocardial injury

DIAGNOSTIC_TEST

NT-pro BNP

Biomarker for heart failure

DIAGNOSTIC_TEST

CRP

Acute phase inflammatory marker

DIAGNOSTIC_TEST

IL1-B

Inflammatory biomarker

DIAGNOSTIC_TEST

IL-6

Inflammatory Biomarker

DIAGNOSTIC_TEST

IL-10

Inflammatory Biomarker

DIAGNOSTIC_TEST

TNF-alpha

Inflammatory Biomarker

Sponsors & Collaborators

  • NHS Ayrshire and Arran

    collaborator OTHER
  • Golden Jubilee National Hospital

    collaborator OTHER_GOV
  • University of Glasgow

    collaborator OTHER
  • NHS Greater Glasgow and Clyde

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-12-31
Completion
2024-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05633290 on ClinicalTrials.gov